Milestone Scientific (MLSS) Liabilities and Shareholders Equity (2010 - 2026)

Milestone Scientific (MLSS) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $8.0 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 12.38% year-over-year to $8.0 million; the trailing twelve-month figure through Mar 2026 stood at $32.3 million (down 23.2% YoY), and the FY2025 full-year result was $7.8 million, down 20.32% from the prior year.
• Liabilities and Shareholders Equity climbed to $8.0 million in Q1 2026, from $7.8 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $19.1 million in Q1 2022 to a low of $7.8 million in Q4 2025.
• A 5-year average of $11.4 million and a median of $11.4 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity slumped 35.62% in 2023 and climbed 5.57% in 2024, its largest moves.
• Tracing MLSS's Liabilities and Shareholders Equity over 5 years: stood at $13.7 million in 2022, then fell by 17.01% to $11.4 million in 2023, then slipped by 13.85% to $9.8 million in 2024, then slipped by 20.32% to $7.8 million in 2025, then gained by 2.01% to $8.0 million in 2026.
• Business Quant data shows MLSS's Liabilities and Shareholders Equity at $8.0 million in Q1 2026, $7.8 million in Q4 2025, and $8.5 million in Q3 2025.